Autonomic nerve function was assessed in 28 diabetic patients with proliferative retinopathy and 61 age-and sex-matched control subjects, using a series of tests based upon cardiovascular reflex responses to standardised stimuli. Autonomic neuropathy was present in 75 per cent of diabetics with proliferative retinopathy, compared with 5.2 per cent of the control group. The implications of a significant association between cardiovascular autonomic neuropathy and proliferative dia betic retinopathy are discussed.
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Autonomic neuropathy has an insidious onset which precludes accurate identification due to the compensatory mechanisms inherent within the autonomic nervous system. Until comparatively recently, tests of autonomic function have been extremely difficult to interpret and almost impossible to quantify. A series of simple, non-invasive tests based upon cardiovascular reflexes have been devel oped during the past 15 years, permitting accurate, objective and reproducible measurement of autonomic nerve func tion.1.2•3,4,5,6 As in all reflex assessments, the subject's output reaction is measured follow ing application of a standardised input stim ulus. Results are based upon blood pressure and heart-rate responses to a variety of stim uli, the relative importance of each compo nent of the reflex having been determined by selective pharmacological autonomic block ade. Evidence to date confirms that these tests reflect damage elsewhere in the autonomic nervous system, and represent generalised autonomic nerve function. 7.8,9 The aim of the present study was to assess systemic autonomic control of cardiovascular function in diabetic patients with abnormal retinal microsvascular proliferation-pro liferative retinopathy.
Patients and Methods
After informed consent had been obtained, cardio vascular autonomic nerve function was assessed in 28 diabetic patients with proliferative retinopathy (mean age 50. 8±14. 3 years) and 61 age-and sex matched control subjects (mean age 53 .1 ±1O. 1 years) . The diabetic group comprised 21 subjects with IDDM (mean age 46. 0±12. 9 years) and 7 subjects with NIDDM (mean age 65. 8±6. 5 years) .
The mean duration of diabetes was 20. 9±8. ute, and the final result is the mean of the differ ences between maximum and minimum heart rates.
(ii) Immediate heart-rate response to standing 
Statistical analysis
Comparisons were made between the results of the control group and diabetic patients with prolifera tive retinopathy; significance was assessed by Stu dent's unpaired t test. Results are expressed as mean ±SEM.
Results
The results of cardiovascular autonomic func tion assessment in 28 diabetic patients with proliferative retinopathy and 61 age-and sex matched control subjects are shown in Table  II 
Sympathetic nerve function
Postural hypotension elevated in diabetics with proliferative reti nopathy (Table III) . Autonomic dysfunction is defined as an abnormal result of at least one autonomic function test. By this criterion, the prevalence of parasympathetic neuropathy in prolifera tive diabetic retinopathy was 67.9 per cent, with sympathetic neuropthy in 28.6 per cent of patients, compared with values in the control group of 2.6 per cent respectively. Neuropa thy involving both parasympathetic and sym pathetic nerves was present in 21.5 per cent of diabetics with proliferative retinopathy; no member of the control group had evidence of both parasympathetic and sympathetic neuropathy.
Glycosylated haemoglobin was moderately elevated in diabetics with proliferative reti nopathy (10.3±0.42 per cent; normal range 6.0-8.5 per cent). Serum creatinine levels were not excessively abnormal in the diabetic group (104. 5±8.31 flmolll; normal range 55-110 flmolll); abnormal results were pres ent in only 5 diabetic patients.
Discussion
Clinical assessment of autonomic nerve func tion based upon cardiovascular reflex tests provides an accurate and quantifiable measurement of a nervous system previously virtually impossible to isolate. Heart-rate is determined by the autonomic nervous system, and represents a balance between sympa thetic and parasympathetic effects.
17.18
Although each test may be used individually, the application of a series of tests provides a detailed assessment of systemic autonomic nerve function.
Diabetes mellitus is the commonest cause of autonomic neuropathy in this country; approximately 17-30 per cent of randomly selected diabetics have abnormal autonomic function, a prevalence confirmed by several large studies. 5.19.20,21 By definition, this popula tion will include patients with proliferative retinopathy, and therefore the prevalence in diabetics without retinopathy is propor tionately less. Cardiovascular autonomic neu ropathy is present in 75 per cent of diabetic subjects with proliferative retinopathy, which is the highest prevalence of secondary autono mic neuropathy recorded to date. Glycaemic control and renal function were not exces sively abnormal in these patients, and there fore this could not be considered merely a manifestation of severity of diabetes.
Similarly, duration of diabetes was relatively unremarkable.
In conciusion, this study has demonstrated a significant association between cardio vascular autonomic neuropathy and prolifera tive diabetic retinopathy. The exact nature of this relationship remains to be defined, how ever severe impairment of autonomic control of the cardiovascular system may be a contrib uting factor to the development of retinal neo vascularisation in diabetes mellitus. 
